Steven Cohen Adma Biologics, Inc. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 103,455 shares of ADMA stock, worth $2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
103,455
Previous 103,455
-0.0%
Holding current value
$2 Million
Previous $1.16 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ADMA
# of Institutions
265Shares Held
178MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$360 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$280 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$254 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$172 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$156 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.79B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...